Research & IP · United States

Caribou Biosciences

Doudna-co-founded CRISPR company holding foundational UC Berkeley Cas9 licences and developing chRDNA-edited allogeneic cell therapies.

Headquarters
Berkeley, United States · North America
Value chain
Research & IP(Research & design)
What that means
Invents and licenses: corporate and contract research, IP and technology licensing, with little production of its own.
Founded
2011
Ownership
Listed
Listing
Nasdaq:CRBU on Google Finance
Website
cariboubio.com
Relevance
Moderate at its strongest, in Synthetic Biology & Genetic Engineering

In 1 capability

Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.

  1. Biotechnology & Health Technologies · Research · listed #22 of 50

    Doudna-co-founded CRISPR company holding foundational UC Berkeley Cas9 licences and developing chRDNA-edited allogeneic cell therapies.

    Relevance: CRISPR company with foundational Cas9 IP

    Source · en.wikipedia.org